Jatinder Singh

Retinal Toxicity, in vivo and in vitro, Associated with Inhibition of Nicotinamide Phosphoribosyltransferase

Tanja S. Zabka, Jatinder Singh, Preeti Dhawan et al. · Toxicological Sciences · 2014 · 85 citations · Full text

Life Sciences, Biochemistry, Pharmacology +15

Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries

James Glasbey, Tom Abbott, Adesoji Ademuyiwa et al. · The Lancet · 2022 · 75 citations · Full text

Nursing, Health Systems, Surgery +15

A Phase Ib Study to Evaluate the MEK Inhibitor Cobimetinib in Combination with the ERK1/2 Inhibitor GDC-0994 in Patients with Advanced Solid Tumors

Colin D. Weekes, A. Craig Lockhart, Patricia LoRusso et al. · The Oncologist · 2020 · 53 citations · Full text

Pharmacy, Oncology, Pharmacokinetics +13

Improved survival and tumor control with Interleukin-2 is associated with the development of immune-related adverse events: data from the PROCLAIMSM registry

Brendan D. Curti, Gregory A. Daniels, David F. McDermott et al. · Journal for ImmunoTherapy of Cancer · 2017 · 38 citations · Full text

Pharmacy, Immunology, Oncology +14

Preclinical models of nicotinamide phosphoribosyltransferase inhibitor-mediated hematotoxicity and mitigation by co-treatment with nicotinic acid

Jacqueline M. Tarrant, Preeti Dhawan, Jatinder Singh et al. · Toxicology Mechanisms and Methods · 2015 · 30 citations

Medicine, Oncology, Pharmacology +17